Niva Bupa Health Insurance Company Ltd
Press release on the unaudited financial results for the quarter ended June, 2026.
RESULTS
▲ Positive Development
LOW RISK
📅 Filed on BSE: 30 Jul 2026, 04:26 PM IST · BSE ID: 0222bec4-cd4e-45a3-b320-b9bea476d1ef
View Original BSE Filing (PDF)
💡
In Simple Terms
Niva Bupa's first-quarter profit jumped 93% to ₹138 crore, with premium income rising 32%.
🤖 AI Summary
- Niva Bupa reported Profit After Tax (PAT) of ₹138 crore for Q1 FY27, a 93% year-on-year increase.
- Gross Written Premium (GWP) for the quarter ended June 30, 2026, stood at ₹2,150 crore, up 32%.
- Retail Health Market Share increased to 11.1% in Q1 FY27, driven by 47% growth in retail health.
- Claim Settlement Ratio improved to 95.6%, and Combined Insurance Service Ratio (CISR) to 100.2%.
- Direct Business emerged as the fastest-growing distribution channel for the quarter.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Profit After Tax (PAT)
₹138 crore
93%
Gross Written Premium (GWP)
₹2,150 crore
32%
Retail Health Market Share
11.1%
Retail health business growth
47%
Claim Settlement Ratio
95.6%
Combined Insurance Service Ratio (CISR)
100.2%
🏢 How This Affects the Company
The company's retail health business grew 47%, contributing to an increase in Retail Health Market Share to 11.1%. Diversified distribution channels, including Direct Business and Agency, demonstrated strong momentum.
Profit After Tax increased by 93% to ₹138 crore, supported by a 32% rise in Gross Written Premium to ₹2,150 crore. The Combined Insurance Service Ratio improved to 100.2% from 103.2% in the prior year's Q1.
Operational excellence and customer-centricity are reflected in an improved Claim Settlement Ratio of 95.6% for the quarter. The company maintained over 210 physical branches and a network of 10,600+ empaneled hospitals.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required by shareholders based on this financial results press release.
👤
Who Is Affected
All shareholders are affected as the company's financial performance impacts its intrinsic value. The reported growth in PAT and GWP indicates enhanced operational profitability.
🔍
Management Signal
Management's statements emphasize continued focus on profitable growth, customer trust, disciplined execution, and an effective omnichannel distribution strategy.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Q2 FY27 financial results — check for sustained PAT and GWP growth.
Updates on retail health market share in subsequent quarters.
Trends in Claim Settlement Ratio and Combined Insurance Service Ratio.
LOW RISK
The filing indicates strong financial performance and operational metrics for the quarter.
💡 Investor Takeaway
Niva Bupa reported a Profit After Tax of ₹138 crore for the quarter ended June 30, 2026, representing a 93% year-on-year growth. Gross Written Premium increased by 32% to ₹2,150 crore, and retail health market share reached 11.1%.
⚖️ Strengths & Concerns
✅ Positives
- Profit After Tax (PAT) increased by a robust 93% year-on-year to ₹138 crore, indicating strong profitability growth.
- Gross Written Premium (GWP) grew by 32% to ₹2,150 crore, supported by 47% growth in the retail health business.
📅 Company Track Record
Niva Bupa reported 80% PAT growth to ₹366 crore for FY26, with GWP up 27% in May 2026 filings. This Q1 FY27 performance continues a trend of strong profitability and premium growth.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What was Niva Bupa's Profit After Tax for the quarter ended June 30, 2026?
Niva Bupa's Profit After Tax (PAT) was ₹138 crore for the quarter ended June 30, 2026, marking a 93% year-on-year growth.
What was the Gross Written Premium (GWP) for Niva Bupa in Q1 FY27?
Niva Bupa reported Gross Written Premium (GWP) of ₹2,150 crore for the quarter ended June 30, 2026, an increase of 32%.
What is Niva Bupa's Retail Health Market Share as of June 30, 2026?
Niva Bupa's Retail Health Market Share increased to 11.1% as of June 30, 2026, following 47% growth in its retail health business.
What was Niva Bupa's Claim Settlement Ratio for the quarter ended June 30, 2026?
Niva Bupa's Claim Settlement Ratio improved to 95.6% during the quarter ended June 30, 2026.
Questions based on this BSE filing only. For information purposes.